๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
This study is being done to learn if yohimbine, a naturally occurring drug,...
Status
Completed
Location
Mayo Clinic
Start Date
2005-06
Trial ID
NCT00217048
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can bl...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-01
Trial ID
NCT00301821
Treatments Being Tested
This phase II trial is studying how well giving combination chemotherapy to...
Status
Completed
Location
SWOG
Start Date
2005-06
Trial ID
NCT00121199
Blood flow autoregulation is defined as the ability of a tissue to maintain...
Status
Completed
Location
Department of Clinical Pharmacology, Medical University of Vienna
Start Date
TBD
Trial ID
NCT00814047
Treatments Being Tested
Objectives: A. Primary objective: 1 To assess the feasibility and the eff...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09-12
Trial ID
NCT00866749
Aim: To investigate the effect of melatonin in bedwetting....
Status
Unknown
Location
Center of Child Incontinence, Pediatric department, Aarhus Universityhospital
Start Date
2012-01
Trial ID
NCT01575678
To determine the efficacy of Stealth liposomal doxorubicin hydrochloride (D...
Status
Completed
Location
Beth Israel Hosp
Start Date
TBD
Trial ID
NCT00002105
Treatments Being Tested
This is a phase II trial of Doxil on day 1 and vinorelbine on days 1 and 2 ...
Status
Unknown
Location
Hematology Oncology Consultants, Inc
Start Date
2003-10
Trial ID
NCT00159094
Treatments Being Tested
The purpose of this study is to determine the safety and feasibility of per...
Status
Recruiting
Location
Ghent University Hospital
Start Date
2024-05-21
Trial ID
NCT06378229
Treatments Being Tested